Jntl Consumer Health I(Switzerland)Gmbh Zug
Business Opportunity Assessment Report

Company Snapshot

JNTL Consumer Health I (Switzerland) GmbH Zug is a Dominican Republic–registered entity operating under a Swiss-named corporate structure. Its core business involves importing health and personal care products—primarily cosmetics, perfumery, and pharmaceutical preparations—for distribution in Latin America. It functions as a specialized importer and regional distributor, not a manufacturer or brand owner. The company exhibits high concentration in Colombian trade flows and shows sharp volume escalation since mid-2024, with transaction counts surging from ~20–50/month to over 400–600/month consistently since Q2 2024.

Company Attributes

Trade Trend Analysis

Data解读: Transaction volume surged over 100× between early 2024 (e.g., 1,392 units in Sep 2023) and peak months in 2025 (2.55M units in May 2025), with transaction frequency stabilizing at 400–650 monthly entries since April 2024 — indicating rapid scaling of operational throughput rather than sporadic activity. The growth is non-linear but sustained, suggesting systematized supply chain activation rather than one-off procurement. This reflects strong execution capacity in logistics and compliance, yet carries elevated dependency risk on Colombia-based partners.

Trade Partner Analysis

Data解读: Over 93% of all transactions (6,068 out of 6,552) are with Johnson & Johnson affiliates — overwhelmingly dominated by Johnson y Johnson de Colombia S.A. (81.3% share). This extreme concentration signals deep channel integration with a single multinational’s Latin American distribution arm, implying standardized ordering, quality control, and regulatory alignment — but also minimal diversification across buyers. This buyer dependency creates material exposure to J&J’s internal procurement policy shifts or regional strategy revisions.

HS Code Analysis

Data解读: Two HS codes — 3304990000 (other beauty/cosmetic preparations) and 3306900000 (dental/medical preparations, n.e.s.) — jointly account for 58.7% of all transactions. This dual-core product architecture aligns with OTC health-and-beauty positioning, supporting cross-category bundling and regulatory harmonization under Andean Community or PAHO-aligned standards. This product focus enables streamlined registration and labeling — but limits flexibility to pivot into high-margin therapeutic categories requiring separate approvals.

Trade Region Analysis

Data解读: Colombia accounts for 92.4% of all transactions, followed distantly by Mexico (6.2%) — confirming a tightly focused regional go-to-market strategy anchored in the Andean market. All other countries represent ≤0.12% shares and mostly reflect historical or experimental engagements, with no evidence of active expansion beyond these two jurisdictions. This geographic hyper-concentration implies optimized local compliance infrastructure — but exposes revenue to Colombian import policy volatility, FX risk, or tax reform.

Export Port Analysis

Data解读: Over 90% of shipments clear through Especial de Cartagena, Colombia’s largest and most modern port with dedicated health-product handling zones — strongly correlating with the overwhelming Colombian trade share and suggesting end-customer proximity and regulatory familiarity. Minor secondary ports (e.g., Manzanillo, Cali) appear only intermittently, reinforcing centralized logistics design. This port concentration enhances customs predictability but reduces contingency options during port congestion or labor disruptions.

Contact Information

No official website, email, phone number, or social media profile (LinkedIn, Facebook, Twitter) was identified via open-source search. No corporate registry record or press release found for "JNTL Consumer Health I (Switzerland) GmbH Zug" in Switzerland or the Dominican Republic. Contact details remain unavailable.

Company Trade Summary

• Dominated by a single buyer (J&J Colombia), representing >93% of all trade activity.
• Core product portfolio centers on HS 3304 (cosmetics) and HS 3306 (dental/medical preps), enabling regulatory efficiency in LATAM markets.
• Operates almost exclusively through Colombia’s Especial de Cartagena port — signaling mature, localized import infrastructure.
• Shows explosive growth since Q2 2024, with transaction volume increasing >100× year-on-year.
• Zero digital footprint: no verifiable website, contact info, or corporate presence found online.